S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
CDT · CDT Equity Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
CDT Equity Inc (CDT)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$0.14
-0.01
(-8.45%)
● At close: October 21 at 4:00:00 PM EDT
$0.14
-0.00
(-2.49%)
Overnight:
10:00:21 PM EDT
DAY'S RANGE
$0.14
$0.14
$0.16
52-WEEK RANGE
$0.14
$0.15
$22327.50
What's happening
- CDT is down 8.45% today, trading at $0.14. — Live quote
- It's trading within 3% of its 52-week low ($0.15). (Finnhub fundamentals)
- Volume today (12,426) is well below its 3-month average of 612,250. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CDT
-100.00%
vs S&P 500
-112.78%
1-YEAR RETURN
CDT
-100.00%
vs S&P 500
-114.56%
6-MONTH RETURN
CDT
-99.98%
3-MONTH RETURN
CDT
-99.83%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-8.71
Est. $—
Valuation Measures & Ratios
Enterprise Value4$568.8K
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)—
Price / Book70.03
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin—
Operating Margin—
Return on Equity (ROE8)-22.30%
Return on Assets (ROA9)-55.44%
Avg Volume (3M)612,250
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $7.6M | $106.2M | $1.79B | $7.7M | $76.7M |
| P/E | -0.35 | -4.84 | -73.38 | -0.34 | -3.81 |
| Price/Book | 0.07 | 1.01 | 417.86 | 2.19 | 24.91 |
| ROE | -21.19% | -20.83% | -569.42% | -641.12% | -654.19% |
| ROA | -17.24% | -17.28% | -284.85% | -283.20% | -275.22% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short38,202
Change from Prior Settlement-84.08%
% of Float—
Days to Cover (Short Ratio)1.00
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-13; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Trailing 52-week price return is -100.0%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CDT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$3.0M | -$3.7M | -$7.0M | -$5.0M | -$3.6M | -$5.8M | -$3.1M | -$3.0M |
| Net income | -$4.6M | -$4.1M | -$7.1M | -$6.0M | -$4.8M | -$6.5M | -$5.4M | -$3.6M |
| EPS (diluted) | $-8.71 | $-5.56 | $-13.16 | $-10940.11 | $-3670.27 | $-889.58 | $-109.33 | $-4.81 |
| EPS (basic) | $-8.71 | $-5.56 | $-13.16 | $-10940.11 | $-3670.27 | $-889.58 | $-109.33 | $-4.81 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $126.7M | $127.1M | $5.7M | $8.6M | $8.0M | $7.3M | $4.2M | $3.0M |
| Total liabilities | $23.6M | $21.6M | $12.8M | $4.3M | $4.5M | $4.6M | $11.0M | $12.1M |
| Stockholders' equity | $103.1M | $105.5M | -$7.2M | $4.3M | $3.5M | $3.1M | -$6.8M | -$9.1M |
| Total current assets | $2.9M | $3.1M | $4.4M | $7.1M | $6.4M | $5.9M | $2.7M | $1.4M |
| Total current liabilities | $23.4M | $21.6M | $12.8M | $4.3M | $4.4M | $4.5M | $10.7M | $12.0M |
| Cash & equivalents | $747.0K | $97.0K | $1.5M | $3.8M | $3.3M | $2.1M | $554.0K | $71.0K |
| Marketable securities (current) | — | — | — | — | — | $600.0K | $600.0K | — |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $158.0K | $213.0K | $269.0K | $325.0K | $381.0K | $41.0K | $40.0K | $48.0K |
| Accounts payable | $3.7M | $2.4M | $1.9M | $613.0K | $1.3M | $714.0K | $1.4M | $1.9M |
| Accrued liabilities | $9.6M | $9.6M | $9.6M | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | — | — | — | — | — | $19.0K | $14.0K | $10.0K |
| Retained earnings | -$77.0M | -$72.4M | -$68.3M | -$47.0M | -$39.9M | -$34.2M | -$29.1M | -$26.7M |
| Accumulated other comprehensive income (loss) | $158.0K | $231.0K | -$16.0K | $217.0K | $269.0K | $346.0K | $414.0K | $271.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$544.0K | -$1.9M | -$4.6M | -$4.4M | -$2.6M | -$3.9M | -$3.8M | -$2.0M |
| Investing cash flow | — | — | $595.0K | -$998.0K | -$1.0K | -$404.0K | $85.0K | $96.0K |
| Financing cash flow | $1.2M | $487.0K | $1.7M | $6.0M | $3.8M | $5.9M | $4.2M | $1.7M |
| Free cash flow | — | — | — | — | -$3.0M | -$3.9M | -$3.8M | -$2.0M |
| Capital expenditures | — | — | — | — | $401.0K | $4.0K | $0 | $41.0K |
| Share-based compensation | $200.0K | $198.0K | $211.0K | $1.6M | $160.0K | $234.0K | $362.0K | $356.0K |
| Deferred income taxes | — | — | — | — | — | — | -$3.0M | — |
| Change in accounts payable | $1.3M | $532.0K | $1.3M | -$604.0K | $485.0K | -$721.0K | -$419.0K | $833.0K |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | $106.0K | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Operating income | -$36.8M | -$15.4M | -$5.3M | -$3.2M |
| Net income | -$39.2M | -$17.8M | -$535.0K | -$4.9M |
| EPS (diluted) | $-1177.89 | $-61598.62 | $-8.92 | $-0.13 |
| EPS (basic) | $-1177.89 | $-61598.62 | $-0.79 | $-0.13 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|
| Total assets | $5.7M | $4.2M | $7.2M | — | $900.0K |
| Total liabilities | $12.8M | $11.0M | $7.7M | — | — |
| Stockholders' equity | -$7.2M | -$6.8M | -$457.0K | — | -$14.5M |
| Total current assets | $4.4M | $2.7M | $5.7M | — | $895.0K |
| Total current liabilities | $12.8M | $10.7M | $1.8M | — | — |
| Cash & equivalents | $1.5M | $554.0K | $4.2M | — | — |
| Marketable securities (current) | — | $4.2M | $4.2M | — | — |
| Property, plant & equipment | $269.0K | $40.0K | — | — | — |
| Accounts payable | $1.9M | $1.4M | $215.0K | — | — |
| Accrued liabilities | $9.6M | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — |
| Common stock & paid-in capital | — | $14.0K | $7.0K | — | — |
| Retained earnings | -$68.3M | -$29.1M | -$11.3M | -$11.5M | -$14.5M |
| Accumulated other comprehensive income (loss) | -$16.0K | $414.0K | $411.0K | — | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Operating cash flow | -$15.6M | -$9.7M | -$7.7M | -$2.3M |
| Investing cash flow | -$808.0K | -$43.0K | $725.0K | -$183.0K |
| Financing cash flow | $17.4M | $6.1M | $10.9M | $2.4M |
| Free cash flow | — | -$9.7M | — | — |
| Capital expenditures | — | $51.0K | — | — |
| Share-based compensation | $2.2M | $1.6M | $199.0K | — |
| Deferred income taxes | — | -$3.0M | -$1.4M | — |
| Change in accounts payable | $434.0K | $1.2M | $215.0K | — |
| Purchases of investments | — | — | — | $134.9M |
| Share repurchases | $106.0K | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CDT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-11-18 to 2026-08-28
Recent transactions
- Insiders have net sold 2,068,290 shares over the last 182 days, across 0 purchases and 5 sales.
- Most recent: Regan Andrew (Chief Executive Officer) — Other acquisition/disposition of 5,436,830 shares on 2026-08-28.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)2,068,290 sh(5 txns)
Net Shares-2,068,290
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Regan Andrew | Chief Executive Officer | Other acquisition/disposition | 2026-08-28 | 5,436,830 |
| Taylor Mark Andrew | 10% owner | Open market sale | 2026-06-18 | 5,000 |
| Farley Chele Chiavacci | Director | Grant / award | 2026-02-19 | 10,553 |
| Bligh James | CFO | Grant / award | 2025-09-19 | 480,000 |
| Fry Simon Jeremy | Director | Grant / award | 2025-08-12 | 35,000 |
| Lewis-Hall Freda C | Director | Grant / award | 2025-08-12 | 35,000 |
| Charles Faith L. | Director | Grant / award | 2025-04-16 | 115,194 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-28 | Regan Andrew | Chief Executive Officer | Other acquisition/disposition | 5,436,830 | — |
| 2026-08-28 | Regan Andrew | Chief Executive Officer | Open market sale | 290 | — |
| 2026-06-18 | Taylor Mark Andrew | 10% owner | Open market sale | 5,000 | $0.71 |
| 2026-06-18 | Taylor Mark Andrew | 10% owner | Open market sale | 1,464,711 | $1.44 |
| 2026-06-18 | Taylor Mark Andrew | 10% owner | Open market sale | 5,000 | $0.75 |
| 2026-06-18 | Taylor Mark Andrew | 10% owner | Open market sale | 593,289 | $1.40 |
| 2026-05-13 | Regan Andrew | Chief Executive Officer | Grant / award | 100,000 | $1.90 |
| 2026-03-24 | Regan Andrew | Chief Executive Officer | Grant / award | 147,401 | — |
| 2026-03-17 | Taylor Mark Andrew | 10% owner | Other acquisition/disposition | 51,420,358 | $0.00 |
| 2026-02-19 | Taylor Mark Andrew | 10% owner | Other acquisition/disposition | 46,902 | $0.00 |
| 2026-02-19 | Farley Chele Chiavacci | Director | Grant / award | 10,553 | $1.04 |
| 2025-12-08 | Regan Andrew | Chief Executive Officer | Grant / award | 224,800 | $1.79 |
| 2025-09-19 | Regan Andrew | Chief Executive Officer | Grant / award | 1,120,000 | $0.69 |
| 2025-09-19 | Bligh James | CFO | Grant / award | 480,000 | $0.00 |
| 2025-08-12 | Fry Simon Jeremy | Director | Grant / award | 35,000 | $0.00 |
| 2025-08-12 | Lewis-Hall Freda C | Director | Grant / award | 35,000 | $0.00 |
| 2025-08-12 | Farley Chele Chiavacci | Director | Grant / award | 35,000 | $0.00 |
| 2025-06-03 | Regan Andrew | Chief Executive Officer | Grant / award | 154,799 | $3.23 |
| 2025-04-16 | Charles Faith L. | Director | Grant / award | 115,194 | $0.87 |
| 2025-03-30 | Lewis-Hall Freda C | Director | Grant / award | 47,612 | $0.89 |
| 2025-03-30 | Fry Simon Jeremy | Director | Grant / award | 29,354 | $0.89 |
| 2025-03-30 | Farley Chele Chiavacci | Director | Grant / award | 32,022 | $0.89 |
| 2025-03-30 | Charles Faith L. | Director | Grant / award | 46,629 | $0.89 |
| 2024-11-18 | Lewis-Hall Freda C | Director | Grant / award | 437,976 | $0.09 |
| 2024-11-18 | Farley Chele Chiavacci | Director | Grant / award | 299,238 | $0.09 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 22:41 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-13 | 8-K | 2026-10-06 | View on SEC.gov → |
| 2026-09-25 | 8-K | 2026-09-24 | View on SEC.gov → |
| 2026-09-18 | 8-K | 2026-09-14 | View on SEC.gov → |
| 2026-09-04 | 8-K | 2026-08-31 | View on SEC.gov → |
| 2026-09-02 | 4 | 2026-07-30 | View on SEC.gov → |
| 2026-09-01 | 8-K | 2026-08-28 | View on SEC.gov → |
| 2026-09-01 | 8-K | 2026-08-28 | View on SEC.gov → |
| 2026-08-12 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-07-31 | View on SEC.gov → |
| 2026-07-31 | 8-K | 2026-07-30 | View on SEC.gov → |
| 2026-07-29 | 8-K | 2026-07-24 | View on SEC.gov → |
| 2026-07-16 | 8-K | 2026-07-15 | View on SEC.gov → |
Recent news
Headlines about CDT (CDT Equity Inc.). Links open the publisher — we don’t host full articles.
-
Nasdaq Session Unusual Volume Movers: Gainers and Decliners
ChartMill · 2026-10-20 -
Earnhardt Family Shares 75th Anniversary Donation with CDT Kids and Barn Academy
Yahoo Finance · 2026-10-20 -
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 2026-10-20 -
CDT Environmental Technology (CDTG) Stock Forum and Discussion
Moomoo · 2026-10-20 -
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 2026-10-19 -
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 2026-10-19 -
Form 4 CDT Equity Inc For: 18 October By Investing.com
Investing.com Nigeria · 2026-10-18 -
Postmarket Movers for Oct. 16, 2026: BitFuFu, Zone Frontier Among Gainers; ATA Creativity, Zhibao Among Losers
ChartMill · 2026-10-16
No headlines in this category right now — try “All”.